Quality of life across endotypes in chronic rhinosinusitis with nasal polyps (CRSwNP)

Published: 17 February 2025| Version 1 | DOI: 10.17632/3jgw78r6k2.1
Contributor:
Stijn Bogaert

Description

Quantification of the sinonasal quality of life with the SNOT-20 GAV questionnaire in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) with endotype type 2 and non-type 2.

Files

Steps to reproduce

Diagnosis of CRSwNP was established based on patient history, clinical symptoms, nasal endoscopy and CT imaging, in accordance with the 2020 EPOS guidelines. Sinonasal HRQoL was assessed using the SNOT-20 GAV, a validated questionnaire with a maximum score of 100. Polyp size was scored endoscopically to determine the Nasal Polyp Score (NPS) following the classification of the European Academy of Allergy and Clinical Immunology (EAACI).

Institutions

Ruhr-Universitat Bochum

Categories

Biomarker, Inflammation, Nasal Polyposis, Quality of Life, Chronic Sinusitis

Licence